Medium materiality6/10
H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
WVE received an analyst target update from Wedbush.
- Buy rating
- Target $13
- Current price $3.88
- Firm: Wedbush
Key facts
- 01
Target: $13
- 02
Posted price: $3.88
- 03
Analyst firm: Wedbush
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.